Streetbeat News

Analyst Ratings

HES

Hess's (NYSE:HES) short percent of float has fallen 23.36% since its last report, with 3.30 million shares sold short, which is 1.64% of all regular shares available for trading. It would take traders 1.7 days to cover their short positions on average. Hess's peer group average for short interest as a percentage of float is 6.22%, indicating less short interest for Hess than most of its peers.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 2:01 pm

MRNA

Moderna (NASDAQ:MRNA) has received mixed analyst ratings in the last quarter, with one bullish, two indifferent, and one somewhat bearish. The average price target is $152.25, which is higher than the current price of $125.8. However, this represents an 18.29% decrease from the previous average price target of $186.33.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 2:00 pm

CNC

Centene's (NYSE:CNC) short percent of float has risen 3.05% since its last report, with 6.50 million shares sold short, which is 1.35% of all regular shares available for trading. This increase in short interest can signal that investors have become more bearish. However, compared to its peers, Centene has less short interest as a percentage of float (3.45%).

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 2:00 pm

BSX

Boston Scientific's (NYSE:BSX) short percent of float has fallen 3.28% since its last report, indicating a more bullish sentiment towards the stock. The company has 8.48 million shares sold short, which is 0.59% of all regular shares available for trading. Compared to its peers, Boston Scientific has less short interest.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 2:00 pm

CHRD

Over the past 3 months, 12 analysts have published their opinion on Chord Energy (NASDAQ:CHRD) stock, with 8 being bullish and 4 somewhat bullish. The company has an average price target of $197.5, a 3.4% decrease from the previous average price target of $204.45.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 2:00 pm

SIRI

Sirius XM Holdings Inc (NASDAQ:SIRI) shares fell by 6.43% to $6.62 despite no company-specific news. The stock also dropped after multiple firms downgraded their rating following a rally. The company is set to report Q2 results on August 1, with earnings estimates of 7 cents per share and quarterly revenue of $2.24 billion.

Portfolio Pulse from Henry Khederian

July 24, 2023 | 1:58 pm

ALXO

Cantor Fitzgerald analyst Alethia Young has reiterated an Overweight rating on ALX Oncology Holdings (NASDAQ:ALXO) and maintained a $22 price target.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 1:56 pm

GILD

Cantor Fitzgerald analyst Olivia Brayer has reiterated a Neutral rating on Gilead Sciences and maintained a price target of $80.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 1:55 pm

LUMO

Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Lumos Pharma (NASDAQ:LUMO) and maintained a $14 price target.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 1:54 pm

RETA

Cantor Fitzgerald analyst Charles Duncan maintains an Overweight rating on Reata Pharmaceuticals (NASDAQ:RETA) and raises the price target from $110 to $145.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 1:53 pm